KDM1A and neoplasm: The impact of targeting T cell-intrinsic LSD1 on B16 tumor growth is opposite to our previous finding that the ablation of tumor cell-intrinsic LSD1 enhances tumor immunogenicity, suppresses tumor growth and overcomes tumor primary resistance to PD1 blockade therapy31.